Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement

Psychopharmacology (Berl). 1996 Nov;128(2):150-60. doi: 10.1007/s002130050120.

Abstract

The effect of 5-HT1B receptor stimulation on dopamine-mediated reinforcement in rats was investigated using intravenous self-administration of the selective dopamine uptake inhibitor GBR-12909 on an FR5 schedule of reinforcement. Pretreatment with the 5-HT1A/1B receptor agonist CGS-12066B (1-10 mg/kg, IP) dose-dependently reduced the self-administration of GBR-12909 (83 micrograms/injection) by increasing the interval between drug injections, consistent with a enhancement of the reinforcing effects of GBR-12909. Additionally, CGS-12066B pretreatment (3 mg/kg, IP) shifted the dose-effect function for GBR-12909 self-administration to the left. Pretreatment with the selective 5-HT1A receptor agonist 8-OH-DPAT (0.03-1.0 mg/kg, SC) had no significant effect on GBR-12909 self-administration (83 micrograms/injection), indicating that the effect of CGS-12066B is not mediated by the 5-HT1A receptor. Finally, CGS-12066B pretreatment (1-10 mg/kg, IP) did not alter the self-administration of cocaine (0.03-0.5 mg/injection), suggesting that the simultaneous stimulation of multiple 5-HT receptor subtypes by the indirect 5-HT agonist properties of cocaine may mask the effect of 5-HT1B receptor stimulation on DA-mediated reinforcement.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • Animals
  • Cocaine / administration & dosage
  • Conditioning, Operant / drug effects*
  • Dopamine Uptake Inhibitors / administration & dosage*
  • Dose-Response Relationship, Drug
  • Narcotics / administration & dosage
  • Piperazines / administration & dosage*
  • Quinoxalines / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptor, Serotonin, 5-HT1B
  • Receptors, Serotonin / drug effects*
  • Self Administration
  • Serotonin Receptor Agonists / pharmacology*

Substances

  • Dopamine Uptake Inhibitors
  • Narcotics
  • Piperazines
  • Quinoxalines
  • Receptor, Serotonin, 5-HT1B
  • Receptors, Serotonin
  • Serotonin Receptor Agonists
  • CGS 12066B
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • vanoxerine
  • Cocaine